Machine learning classifiers aid virtual screening for efficient design of mini-protein therapeutics.
In this study we trained machine learning classifiers which can distinguish, with 90% accuracy and 80% precision, mini-protein binders from non-binding molecules designed for a particular target; this significantly reduces the number of mini protein candidates for experimental screening. Further, on the basis of our results we propose a multi-stage protocol where a small dataset (few hundred experimentally verified target-specific mini-proteins) can be used to train classifiers for improving the efficiency of mini-protein design for any specific target.
PMID: 33609660 [PubMed - as supplied by publisher]
Source: Bioorganic and Medicinal Chemistry Letters - Category: Chemistry Authors: Gaur NK, Goyal VD, Kulkarni K, Makde RD Tags: Bioorg Med Chem Lett Source Type: research
More News: Chemistry | Laboratory Medicine | Learning | Science | Study | Universities & Medical Training